Cbdaf
Product Images NDC 58443-0366

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cbdaf (NDC 58443-0366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prime Enterprises, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Label (58443 0366 3)

CBDaF Topical Gel by Prime Enterprises is a topical analgesic containing Lidocaine Hydrochloride 4% and Menthol 1%, designed for relief of minor pain. The label includes directions for use, warnings, inactive ingredients, and contact information. The product size is 3 FL OZ (89 mL) with 500 mg CBD per bottle.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.